Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kimco Realty Corporation (HC) Common Stock (KIM) vs Smith & Nephew plc (SNN) Price & Performance

Kimco Realty Corporation (HC) Common StockTrade
Smith & Nephew plcTrade

Price performance (Past 24H)

Key statistics

Kimco Realty Corporation (HC) Common Stock vs Smith & Nephew plc — how do they compare? Kimco Realty Corporation (HC) Common Stock trades at $22.16 (market cap $14.82B), while Smith & Nephew plc trades at $27.24 (market cap $11.10B). The key difference: Kimco Realty Corporation (HC) Common Stock is the larger of the two by market cap, and Kimco Realty Corporation (HC) Common Stock pays the higher dividend (5.07%). Which is the better fit depends on your goals — on Pluang, investors hold Kimco Realty Corporation (HC) Common Stock for 1 Days and Smith & Nephew plc for 121 Days on average.

KIMSNN
Market Cap
$14.82B$11.10B
Volume
5,158,4621,051,703
Sector
Real EstateHealth
52-Week High
$26.38$37.17
52-Week Low
$19.78$26.42
Typical Hold Time
1 Days121 Days
Enterprise Value
$22.98B$14.13B
Dividend Yield
5.07%2.95%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Kimco Realty Corporation (HC) Common Stock

No Aura AI signal available yet.

Smith & Nephew plc

SNN trades at $26.96, up 0.26% on the day, but near its 52-week low amid a bearish technical signal. Recent earnings have mostly beaten expectations, with Q2 2026 EPS of $0.946 exceeding the $0.939 estimate. Revenue grew to $6.16B in 2025, and net income margin improved to 10.08%. The company continues to launch new medical products, such as the EVOS PELVIC System, to drive growth.

The outlook is mixed; strong fundamentals and product innovation support long-term value, but near-term price pressure and analyst caution pose risks. Investors should weigh robust profitability against competitive threats and recent management changes.

Returns comparison

Trailing returns across standard periods

About Kimco Realty Corporation (HC) Common Stock

Kimco Realty is a real estate investment trust that owns and operates open-air, grocery-anchored shopping centers and mixed-use properties in the United States.

Read more on KIM →

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN →